Skip to content

Validation of the quantitative evaluation technology system for prostate aging health status

Validation of the quantitative evaluation technology system for prostate aging health status

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105362
Enrollment
Unknown
Registered
2025-07-02
Start date
2025-07-03
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign prostatic hyperplasia

Interventions

Gold Standard:The reference criteria for assessing participants’ prostate aging health status will be determined by clinical doctors according to the Chinese Guidelines for Diagnosis and Treatment of
Index test:The result output by the quantitative assessment system for prostate aging

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Physical examination and benign prostatic hyperplasia treatment population of men >= 40 years old; 2. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: Have a history of prostate cancer, PIN, urethral stricture, urethral calculi, urethral tumor, or prostate hyperplasia surgery.

Design outcomes

Primary

MeasureTime frame
Area under the receiver operating characteristic curve;

Secondary

MeasureTime frame
Sensitivity/Specificity;Positive predictive value / Negative predictive value;Accuracy;

Countries

China

Contacts

Public ContactXiantao Zeng

Zhongnan Hospital of Wuhan University

zengxiantao1128@163.com+86 27 6781 2817

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026